3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
23
Lymphoma, Non-Hodgkin
22
Lymphoma, Large B-Cell, Diffuse
16
Hodgkin Disease
16
Lymphoma, Mantle-Cell
13
Lymphoma, Follicular
13
Burkitt Lymphoma
9
Multiple Myeloma
7
Lymphoma, Large-Cell, Immunoblastic
6
Lymphoma, B-Cell
6
Glioblastoma
6
Lymphoma, B-Cell, Marginal Zone
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Leukemia
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, T-Cell
4
Gliosarcoma
4
Glioma
4
Recurrence
3
Neoplasms, Plasma Cell
3
Neoplasms
3
Leukemia, Myeloid, Acute
3
Congenital Abnormalities
3
Astrocytoma
3
Waldenstrom Macroglobulinemia
2
Primary Myelofibrosis
2
Pdgfra-Associated Chronic Eosinophilic Leukemia
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Myelodysplastic Syndromes
2
Interventions
Oxaliplatin
49
Fluorouracil
45
Leucovorin
42
Capecitabine
40
Irinotecan
31
Bevacizumab
31
Radiotherapy
24
Cetuximab
23
Radiation
13
Panitumumab
13
Folfox protocol
10
Surgical Procedures, Operative
9
IFL protocol
8
Radiotherapy, Intensity-Modulated
6
Magnetic Resonance Spectroscopy
6
aflibercept
5
Immunohistochemistry
5
Gene Expression Profiling
5
Chemotherapy, Adjuvant
5
Fluorodeoxyglucose F18
4
Floxuridine
4
Celecoxib
4
trifluridine tipiracil drug combination
3
dehydroftorafur
3
XELOX
3
Sorafenib
3
Ramucirumab
3
Neoadjuvant Therapy
3
Erlotinib Hydrochloride
3
Drug Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Rectal Neoplasms
×
Carmustine
×
Clear all
No trials found.